Indication - Malaria
Glucose-6-phosphate dehydrogenase(G6PD)
Facility level:
Assay formats
Semi-quantitative fluorescent spot test
Status history
First added in 2018
Changed in 2020
Purpose type
Screening, Determination of Physiological Status
To screen newborns for G6PD deficiency; To determine G6PD activity (normal, intermediate, deficient) for a decision to administer oxidant drugs, e.g. 8-aminoquinoline drugs for radical cure of P. vivax malaria.
Specimen types
Venous whole blood
ICD11 code: 1F45

Summary of SAGE IVD recommendation

The selection of the disease specific diagnostics tests for the EDL took into account the relevant priority diseases for the WHO such as HIV infection, tuberculosis, malaria, viral hepatitis B and C, syphilis and HPV infection. For these diseases there are WHO guidelines and technical reports, including recommendations for the appropriate IVDs. These documents are the result of significant evidence review and formed the basis for the inclusion of these IVDs in the EDL.

Details of submission from 2020

The inclusion of this entry was based on WHO guidelines and technical reports that include recommendations for the appropriate IVDs.